SE9303289L - Use of inositol trisphosphate for drug preparation - Google Patents

Use of inositol trisphosphate for drug preparation

Info

Publication number
SE9303289L
SE9303289L SE9303289A SE9303289A SE9303289L SE 9303289 L SE9303289 L SE 9303289L SE 9303289 A SE9303289 A SE 9303289A SE 9303289 A SE9303289 A SE 9303289A SE 9303289 L SE9303289 L SE 9303289L
Authority
SE
Sweden
Prior art keywords
drug preparation
inositol trisphosphate
trisphosphate
inositol
drug
Prior art date
Application number
SE9303289A
Other languages
Unknown language ( )
Swedish (sv)
Other versions
SE501793C2 (en
SE9303289D0 (en
Inventor
Matti Siren
Original Assignee
Perstorp Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Perstorp Ab filed Critical Perstorp Ab
Priority to SE9303289A priority Critical patent/SE501793C2/en
Publication of SE9303289D0 publication Critical patent/SE9303289D0/en
Priority to EP94929713A priority patent/EP0724445A1/en
Priority to AU78668/94A priority patent/AU7866894A/en
Priority to PCT/SE1994/000928 priority patent/WO1995010285A1/en
Priority to JP7511669A priority patent/JPH09503519A/en
Publication of SE9303289L publication Critical patent/SE9303289L/en
Publication of SE501793C2 publication Critical patent/SE501793C2/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

The present invention relates to the use of inositoltrisphosphate (IP3) for the preparing of a medicament effective against retroviral diseases.
SE9303289A 1993-10-08 1993-10-08 Use of inositol trisphosphate for drug preparation SE501793C2 (en)

Priority Applications (5)

Application Number Priority Date Filing Date Title
SE9303289A SE501793C2 (en) 1993-10-08 1993-10-08 Use of inositol trisphosphate for drug preparation
EP94929713A EP0724445A1 (en) 1993-10-08 1994-10-06 The use of inositoltrisphosphate for the preparing of medicaments
AU78668/94A AU7866894A (en) 1993-10-08 1994-10-06 The use of inositoltrisphosphate for the preparing of medicaments
PCT/SE1994/000928 WO1995010285A1 (en) 1993-10-08 1994-10-06 The use of inositoltrisphosphate for the preparing of medicaments
JP7511669A JPH09503519A (en) 1993-10-08 1994-10-06 Use of inositol triphosphate for drug preparation.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9303289A SE501793C2 (en) 1993-10-08 1993-10-08 Use of inositol trisphosphate for drug preparation

Publications (3)

Publication Number Publication Date
SE9303289D0 SE9303289D0 (en) 1993-10-08
SE9303289L true SE9303289L (en) 1995-04-09
SE501793C2 SE501793C2 (en) 1995-05-15

Family

ID=20391349

Family Applications (1)

Application Number Title Priority Date Filing Date
SE9303289A SE501793C2 (en) 1993-10-08 1993-10-08 Use of inositol trisphosphate for drug preparation

Country Status (5)

Country Link
EP (1) EP0724445A1 (en)
JP (1) JPH09503519A (en)
AU (1) AU7866894A (en)
SE (1) SE501793C2 (en)
WO (1) WO1995010285A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998044935A2 (en) * 1997-04-09 1998-10-15 Viron Corporation Antiviral composition containing oxidized inositol, sodium sulfite, pyrocatechol and copper sulfate
DE19958181A1 (en) 1999-12-02 2001-06-07 Clariant Gmbh Pigment dispersants based on diketopyrrolopyrrole compounds and pigment preparations

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5082833A (en) * 1988-06-30 1992-01-21 Shamsuddin Abulkalam M Reduction of cell proliferation and enhancement of nk-cell activity

Also Published As

Publication number Publication date
SE501793C2 (en) 1995-05-15
AU7866894A (en) 1995-05-04
SE9303289D0 (en) 1993-10-08
WO1995010285A1 (en) 1995-04-20
EP0724445A1 (en) 1996-08-07
JPH09503519A (en) 1997-04-08

Similar Documents

Publication Publication Date Title
EP0552256A4 (en)
NO20101190L (en) Use of buprenorphine in the manufacture of a medicament
NO174877C (en) Process for the preparation of a drug having antitumor effect
ES2017820A6 (en) Carboxamide compounds, processes for preparing the same and a pharmaceutical composition containing the same
AU4048295A (en) Peptide medicaments for the treatment of disease
MY102565A (en) Novel derivatives of guanine
NO163356C (en) PROCEDURE FOR THE PREPARATION OF A PHARMACEUTICAL TABLETS WHICH PROVIDES PRINCIPLY ZERO ORDER'S RELEASE OF MEDICINE.
ES2119185T3 (en) TREATMENT OF MICOBACTERIAL DISEASES BY ADMINISTRATION OF BACTERICIDE PROTEIN PRODUCTS / INCREASES PERMEABILITY.
LV11985A (en) Determine the pharmacological use of a cystine derivative
SE9200547D0 (en) A PHARMACEUTICAL COMPOSITION WITH IMPROVED BIOAVAILABILITY OF INOSITOL PHOSPHATE
DE3880667D1 (en) AMPULLE FOR THE CONTROLLED ADMINISTRATION OF A MEDICINAL PRODUCT.
SE9303853L (en) Use of an inositol trisphosphate ester for drug preparation
DK376188D0 (en) PHARMACEUTICAL DOSAGE UNIT
SE9404568L (en) Use of inositol trisphosphate for drug preparation
SE9303289L (en) Use of inositol trisphosphate for drug preparation
DK400887D0 (en) USE OF 15-DEOXYSPERGUALIN FOR THE PREPARATION OF A MEDICINAL PRODUCT
DE69412612D1 (en) DESOXYAZAPHOSPHOLIPID DERIVATIVES WITH INHIBITING ACTIVITY ON PHOSPHOLIPASE
SE9203296L (en) Use of inositol travel phosphate for drug preparation
SE9303855L (en) Use of an inositol trisphosphate ester for the preparation of an analgesic drug
SE9504594L (en) Use of an ester of inositol trisphosphate for drug preparation
HUP0004647A2 (en) Use of glycosaminoglycans for producing pharmaceutical preparations for treating diabetes-associated diseases of the eye
ZA897549B (en) Medicament for the treatment of diseases caused by retroviruses
ES2060162T3 (en) USE OF MONOCLONAL ANTI-B2 MICROGLOBULIN ANTIBODIES.
CA2033975A1 (en) Use of .beta.-receptor blocking agents
FR2390421A1 (en) 1-ACYL-2-HYDROXY-1,3-DIAMINOPROPANES AS NEW MEDICINES

Legal Events

Date Code Title Description
NUG Patent has lapsed

Ref document number: 9303289-4

Format of ref document f/p: F